Cyclacel Pharmaceuticals Inc (CYCC)
2.00
-0.49
(-19.68%)
USD |
NASDAQ |
May 03, 16:00
2.02
+0.02
(+1.00%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -0.006M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.003M |
| March 31, 2022 | -0.004M |
| December 31, 2021 | -0.002M |
| September 30, 2021 | -0.009M |
| June 30, 2021 | 0.062M |
| March 31, 2021 | -0.078M |
| December 31, 2020 | -0.042M |
| September 30, 2020 | -0.05M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.004M |
| December 31, 2019 | 0.006M |
| September 30, 2019 | -0.004M |
| June 30, 2019 | -0.001M |
| March 31, 2019 | 0.027M |
| December 31, 2018 | -0.006M |
| September 30, 2018 | -0.002M |
| June 30, 2018 | -0.009M |
| March 31, 2018 | -0.022M |
| December 31, 2017 | -0.002M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.009M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.002M |
| December 31, 2016 | 0.009M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.071M |
| September 30, 2015 | -0.01M |
| June 30, 2015 | -0.008M |
| March 31, 2015 | 0.009M |
| December 31, 2014 | 0.089M |
| September 30, 2014 | -0.141M |
| June 30, 2014 | 0.062M |
| March 31, 2014 | 0.065M |
| December 31, 2013 | 0.023M |
| September 30, 2013 | -0.007M |
| June 30, 2013 | 5.632M |
| March 31, 2013 | 0.04M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.002M |
| June 30, 2012 | 0.037M |
| March 31, 2012 | 0.015M |
| December 31, 2011 | 0.005M |
| September 30, 2011 | -0.006M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.078M
Minimum
Mar 2021
0.062M
Maximum
Jun 2021
-0.0071M
Average
-0.002M
Median
Dec 2021
Cash from Investing (Quarterly) Benchmarks
| Corvus Pharmaceuticals Inc | -2.318M |
| Oragenics Inc | -1.00M |
| Relmada Therapeutics Inc | 7.741M |
| Alpine Immune Sciences Inc | -112.70M |
| MAIA Biotechnology Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.91M |
| Cash from Financing (Quarterly) | 0.999M |
| Free Cash Flow | -16.12M |
| Free Cash Flow Per Share (Quarterly) | -4.405 |
| Free Cash Flow to Equity (Quarterly) | -3.91M |
| Free Cash Flow to Firm (Quarterly) | -3.91M |
| Free Cash Flow Yield | -947.2% |